W. Cheng

Novel blood biomarkers for heart failure mortality: mechanistic pathways, aging biology, and risk stratification

Heart failure (HF) is a major global health burden associated with high mortality after decompensation, particularly in older patients with multimorbidity. Although established biomarkers such as natriuretic peptides remain essential for initial risk stratification, they capture only a fraction of mortality risk in bio...